← Back to Search

[F-18]MeFAMP PET for Brain Tumors

Phase < 1

Waitlist Available

Led By Jonathan McConathy, MD, PhD

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older at the time of enrollment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from injection to 45 minutes, 2 hours, and 4 hours after pet agent administration.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if a new imaging tech is safe and effective for imaging brain tumors. It will also explore if it can accurately distinguish tumors from radiation effects.

Who is the study for?

This trial is for adults over 18 with a life expectancy of more than 12 weeks. It includes healthy volunteers, those with high-grade glioma after radiation, and patients with brain metastases from other tumors. Women able to have children must test negative for pregnancy.

What is being tested?

[F-18]MeFAMP PET imaging is being tested to see if it's safe and how well it can show primary and metastatic brain tumors. The study has three parts: one for healthy people, one for glioma patients, and another for those with brain metastases.

What are the potential side effects?

Since this is the first time [F-18]MeFAMP PET is used in humans, part of the study aims to establish its safety profile. Potential side effects are not detailed but will be monitored throughout the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from injection to 45 minutes, 2 hours, and 4 hours after pet agent administration.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from injection to 45 minutes, 2 hours, and 4 hours after pet agent administration.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from injection to 45 minutes, 2 hours, and 4 hours after pet agent administration. for reporting.